Disciplined Investments, LLC Xencor Inc Transaction History

Disciplined Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$25.95 - $36.95 $25 - $36	-1 Reduced 25.0%	3 $0
Q4 2022 Feb 01, 2023	BUY	$24.79 - $30.86 $49 - $61	2 Added 100.0%	4 $0
Q3 2022 Nov 03, 2022	BUY	$24.62 - $32.44 $49 - $64	2 New	2 $0
Q2 2022 Aug 09, 2022	SELL	$19.74 - $29.01 $39 - $58	-2 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$26.68 - $41.63 $53 - $83	2 New	2 $0

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.